Paragon 28 Share Price Today
(NASDAQ: FNA)

Name: Paragon 28 Share Price Today (NASDAQ: FNA) - Paragon 28 Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Paragon 28 share price is $11.62 & ₹1,001.53 as on 25 Jan 2025, 2.30 'hrs' IST

$11.62

▲

-0.07

(-0.6%)

Market is closed - opens 8 PM, 27 Jan 2025

View live Paragon 28 share price in Dollar and Rupees. Guide to invest in Paragon 28 stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Paragon 28, along with analyst recommendations, forecasts, and comprehensive financials.

Paragon 28 share price movements

Today's Low: $11.45
Today's High: $11.69
$11.62
1.46%
Downside
Day's Volatility :2.05%
Upside
0.6%
52 Weeks Low: $4.65
52 Weeks High: $14.79
$11.62
59.98%
Downside
52 Weeks Volatility :68.56%
Upside
21.43%

Paragon 28 Returns

Period	Paragon 28, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	141.53%	-3.6%	0.0%
6 Months	34.83%	-3.9%	0.0%
1 Year	-4.8%	3.9%	0.0%
3 Years	-17.15%	11.7%	-13.0%

Paragon 28 Key Statistics

in dollars & INR

Previous Close	$11.69
Open	$11.69
Today's High	$11.69
Today's Low	$11.45
Market Capitalization	$950.2M
Today's Volume	$709.5K
52 Week High	$14.79
52 Week Low	$4.65
Revenue TTM	$245.0M
EBITDA	$-21.5M
Earnings Per Share (EPS)	$-0.67
Profit Margin	-22.92%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-33.71%

How to invest in Paragon 28 Stock (FNA) from India?

It is very easy for Indian residents to invest directly in Paragon 28 from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Paragon 28 stock in both Indian Rupees (INR) and US Dollars (USD). Search for Paragon 28 or FNA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Paragon 28 or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Paragon 28 shares which would translate to 0.074 fractional shares of Paragon 28 as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Paragon 28, in just a few clicks!

Returns in Paragon 28 for Indian investors in Rupees

Investment Value

₹1,00,000

Paragon 28 investment value today

Current value as on today

₹98,374

Returns

₹1,626

(-1.63%)

Returns from Paragon 28 Stock

₹5,375 (-5.37%)

Dollar Returns

₹3,748 (+3.75%)

Indian investors sentiment towards Paragon 28

17%

Period: Oct 26, 2024 to Jan 24, 2025. Change in 30 Days versus previous period

Search volume for Paragon 28 on INDmoney from India has grown in the last 30 days as on Jan 25, 2025. 17% more investors are searching Paragon 28 in the last 30 days versus the previous period.

Global Institutional Holdings in Paragon 28

MVM Partners LLC
13.00%
First Light Asset Management, LLC
12.13%
BRAIDWELL LP
4.94%
BlackRock Inc
4.43%
Vanguard Group Inc
2.85%
Cadian Capital Management LP
2.27%

Analyst Recommendation on Paragon 28

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Paragon 28(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Paragon 28

What analysts predicted

Upside of 23.92%

Target:

$14.40

Current:

$11.62

Insights on Paragon 28

Price Movement
In the last 7 days, FNA stock has moved up by 7.4%
Increasing Revenue
Revenue is up for the last 2 quarters, 61.01M → 62.33M (in $), with an average increase of 2.1% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -19.55M → -12.33M (in $), with an average increase of 16.9% per quarter
FNA vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 69.6% return, outperforming this stock by 73.7%
FNA vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 138.3% return, outperforming this stock by 159.1%
Price to Sales
ForFNA every $1 of sales, investors are willing to pay $4.0, whereas for Boston Scientific Corp., the investors are paying $9.4 for every $1 of sales.

Paragon 28 Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$106.3M	-
Net Income	$3.1M	-
Net Profit Margin	2.93%	-

	FY20	Y/Y Change
Revenue	$111.0M	↑ 4.42%
Net Income	$2.7M	↓ 13.83%
Net Profit Margin	2.42%	↓ 0.51%

	FY21	Y/Y Change
Revenue	$147.5M	↑ 32.87%
Net Income	$-13.7M	↓ 609.79%
Net Profit Margin	-9.29%	↓ 11.71%

	FY22	Y/Y Change
Revenue	$181.4M	↑ 23.0%
Net Income	$-67.3M	↑ 391.68%
Net Profit Margin	-37.12%	↓ 27.83%

	FY23	Y/Y Change
Revenue	$216.4M	↑ 19.3%
Net Income	$-47.8M	↓ 28.94%
Net Profit Margin	-22.11%	↑ 15.01%

	FY24	Y/Y Change
Revenue	$216.4M	↑ 0.0%
Net Income	$-57.5M	↑ 20.26%
Net Profit Margin	-26.59%	↓ 4.48%

	Q2 FY23	Q/Q Change
Revenue	$51.0M	↓ 1.97%
Net Income	$-10.9M	↑ 20.39%
Net Profit Margin	-21.36%	↓ 3.96%

	Q3 FY23	Q/Q Change
Revenue	$52.8M	↑ 3.48%
Net Income	$-8.3M	↓ 23.55%
Net Profit Margin	-15.79%	↑ 5.57%

	Q4 FY23	Q/Q Change
Revenue	$60.6M	↑ 14.74%
Net Income	$-19.6M	↑ 134.75%
Net Profit Margin	-32.3%	↓ 16.51%

	Q1 FY24	Q/Q Change
Revenue	$61.1M	↑ 0.86%
Net Income	$-15.2M	↓ 22.11%
Net Profit Margin	-24.94%	↑ 7.36%

	Q2 FY24	Q/Q Change
Revenue	$61.0M	↓ 0.11%
Net Income	$-13.8M	↓ 9.53%
Net Profit Margin	-22.59%	↑ 2.35%

	Q3 FY24	Q/Q Change
Revenue	$62.3M	↑ 2.16%
Net Income	$-12.3M	↓ 10.48%
Net Profit Margin	-19.79%	↑ 2.8%

	FY19	Y/Y Change
Profit	$87.4M	-

	FY20	Y/Y Change
Profit	$85.9M	↓ 1.79%

	FY21	Y/Y Change
Profit	$119.4M	↑ 39.07%

	FY22	Y/Y Change
Profit	$148.9M	↑ 24.69%

	FY23	Y/Y Change
Profit	$157.2M	↑ 5.59%

	FY24	Y/Y Change
Profit	$164.4M	↑ 4.57%

	Q2 FY23	Q/Q Change
Profit	$42.2M	↓ 2.27%

	Q3 FY23	Q/Q Change
Profit	$42.4M	↑ 0.56%

	Q4 FY23	Q/Q Change
Profit	$40.2M	↓ 5.21%

	Q1 FY24	Q/Q Change
Profit	$48.9M	↑ 21.69%

	Q2 FY24	Q/Q Change
Profit	$45.8M	↓ 6.42%

	Q3 FY24	Q/Q Change
Profit	$46.2M	↑ 0.92%

	FY19	Y/Y Change
Operating Cash Flow	$12.3M	-
Investing Cash Flow	$-17.5M	-
Financing Cash Flow	$6.5M	-

	FY20	Y/Y Change
Operating Cash Flow	$1.1M	↓ 90.97%
Investing Cash Flow	$-10.3M	↓ 40.88%
Financing Cash Flow	$24.0M	↑ 266.88%

	FY21	Y/Y Change
Operating Cash Flow	$-3.3M	↓ 398.56%
Investing Cash Flow	$-35.5M	↑ 243.96%
Financing Cash Flow	$131.1M	↑ 445.96%

	FY22	Y/Y Change
Operating Cash Flow	$-49.2M	↑ 1382.7%
Investing Cash Flow	$-60.7M	↑ 71.01%
Financing Cash Flow	$39.5M	↓ 69.88%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-19.3M	↑ 37.57%
Investing Cash Flow	$-15.3M	↑ 102.11%
Financing Cash Flow	$-2.5M	↓ 103.66%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-14.1M	↓ 27.03%
Investing Cash Flow	$-22.0M	↑ 44.34%
Financing Cash Flow	$-1.4M	↓ 46.73%

Paragon 28 Technicals Summary

Sell

Neutral

Buy

Paragon 28 is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Paragon 28 Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Paragon 28, Inc.	12.95%	34.83%	-4.8%	-17.15%	-37.52%
Medtronic Plc	9.38%	11.56%	3.13%	-14.26%	-25.14%
Edwards Lifesciences Corp.	-9.21%	8.14%	-5.88%	-36.55%	-9.67%
Boston Scientific Corp.	11.14%	34.46%	66.27%	136.15%	138.31%
Stryker Corporation	6.52%	18.07%	26.38%	58.5%	83.36%
Abbott Laboratories	6.9%	17.61%	10.01%	2.62%	37.54%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Paragon 28, Inc.	NA	NA	NA	-0.62	-0.34	-0.08	NA	1.67
Medtronic Plc	27.03	27.03	1.5	5.46	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	26.66	26.66	6.43	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	83.4	83.4	1.79	2.46	0.09	0.05	NA	14.05
Stryker Corporation	42.47	42.47	2.68	12.06	0.19	0.07	0.01	52.86
Abbott Laboratories	34.45	34.45	2.2	4.67	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Paragon 28, Inc.	Buy	$950.2M	-37.52%	NA	-22.92%
Medtronic Plc	Buy	$113.3B	-25.14%	27.03	12.06%
Edwards Lifesciences Corp.	Buy	$40.7B	-9.67%	26.66	65.86%
Boston Scientific Corp.	Buy	$148.7B	138.31%	83.4	11.26%
Stryker Corporation	Buy	$150.9B	83.36%	42.47	16.34%
Abbott Laboratories	Buy	$202.6B	37.54%	34.45	13.99%

About Paragon 28

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Organization	Paragon 28
Employees	574
CEO	Mr. Albert DaCosta
Industry	Healthcare

Management People of Paragon 28

Name	Title
Mr. Albert DaCosta	Co-Founder, Chairman, President & CEO
Mr. Robert S. McCormack J.D.	General Counsel & Secretary
Mr. Matthew Jarboe	Executive VP of Sales & Chief Commercial Officer
Mr. Andrew James Hill	Executive Vice President of Research & Development
Mr. Chadi Chahine	CFO & Executive VP of Supply Chain Operations
Mr. Matthew Brinckman	Senior Vice President of Strategy & Investor Relations
Mr. Brendan Shook	Executive VP of Marketing & Medical Education
Dr. Matthew Millard	Chief Human Resources Officer
Mr. John Shumaker	Executive Vice President of Sales - U.S.
Mr. Hans Kestler	Executive Vice President of International

Important FAQs about investing in Paragon 28 (FNA) from India :

What is Paragon 28 share price today?

Paragon 28 share price today stands at $11.62, Open: $11.69 ; Previous Close: $11.69 ; High: $11.69 ; Low: $11.45 ; 52 Week High: $14.79 ; 52 Week Low: $4.65. The stock opens at $11.69, after a previous close of $11.69. The stock reached a daily high of $11.69 and a low of $11.45, with a 52-week high of $14.79 and a 52-week low of $4.65.

Can Indians buy Paragon 28 shares?

Yes, Indians can invest in the Paragon 28 (FNA) from India.

With INDmoney, you can buy Paragon 28 at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Paragon 28 at zero transaction cost.

How can I buy Paragon 28 shares from India?

It is very easy to buy Paragon 28 from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Paragon 28 be purchased?

Yes, you can buy fractional shares of Paragon 28 with INDmoney app.

What are the documents required to start investing in Paragon 28 stocks?

To start investing in Paragon 28, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.